Search Results

The VACUTAINER® Brand PPT™ Plasma Preparation Tube with HDTA anticoagulant and a gel barrier material are evacuated blood collection which provide a means of collecting, processing and transporting blood in a closed plastic tube. When the Tube is .. used together with VACUPAINER® Brand needles and holders, it is a closed system for the collection of venous blood with the same indications identified here.

Blood collected in a tube containing HDTA anticoagulant and gel barrier material can be primarily used to provide undiluted plasma for use in molecular diagnostic test methods; including but not limited to Polymerase Chain Reaction (PCR) and branched-DNA (bDNA). The specimen may also be used for other testing that requires an undiluted plasma sample as determined by the laboratory.

The VACUTAINER® Brand PPT™-Plasma Preparation Tube (blood collection The VACOTAINER® Brand Property is an evacuated plastic tube containing EDTA Antiocagana, processing and transporting blood in a blood obliobiler Rabe for Selleum NER® Brand PPT™ consists of a Closed plastic tube. The VAOS v. ... .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (dipotassium or tripotassium) and a polymeric gel barrier material.

The provided text describes the 510(k) summary for the VACUTAINER® Brand PPT™-Plasma Preparation Tube, which is a blood specimen collection device. The studies are designed to demonstrate substantial equivalence to existing predicate devices, rather than establishing specific acceptance criteria for performance metrics of a novel device. The primary evaluation is focused on comparisons of HIV and HCV viral load measurements.

Here's an analysis of the requested information based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state numerical acceptance criteria in the typical sense (e.g., minimum sensitivity or specificity targets). Instead, the acceptance criterion for the device seems to be "statistically and clinically equivalent results" and "equivalent results" when compared to predicate devices for viral load determinations.

Given this, the table would look like this:

2. Sample Sizes Used for the Test Set and Data Provenance

• Study I (HIV): 56 HIV-Positive patients.
• Studies III & IV (HIV): 40 HIV-positive subjects.
• Study II (HCV b-DNA): 49 paired samples from 24 HCV negative and 25 HCV positive subjects.
• Studies V & VI (HCV PCR): 65 HCV-positive patients.

Data Provenance: The document does not specify the country of origin of the data. It appears to be prospective as it mentions "paired samples were collected."

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The ground truth in this context refers to the viral load measurements themselves, as determined by established molecular diagnostic kits (e.g., Roche Amplicor® HIV RT PCR Monitor™ Kit, Chiron Quantiplex HCV RNA Assay). The document does not mention the use of experts to establish a "ground truth" other than the performance of these assays. There is no indication of expert consensus or adjudication in this regard; the assays themselves are the reference.

4. Adjudication Method for the Test Set

No adjudication method (e.g., 2+1, 3+1) is mentioned. The studies involve direct comparison of viral load measurements obtained from different tubes using standard laboratory assays.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is a medical device for blood collection and preparation, not an AI-powered diagnostic tool. Therefore, an MRMC study and analysis of human reader improvement with AI assistance are not applicable to this device.

6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done

This is a physical medical device (blood collection tube) and does not involve an algorithm. Therefore, a standalone algorithm performance study is not applicable.

7. The Type of Ground Truth Used

The "ground truth" for the performance evaluation was established by viral load measurements using commercially available and validated molecular diagnostic kits (e.g., Roche Amplicor® HIV RT PCR Monitor™ Kit, Amplicor® HCV RT PCR Monitor - Test Kit, Chiron Quantiplex HCV RNA Assay) on blood samples. These kits are considered the reference standard for viral load quantification.

8. The Sample Size for the Training Set

The document does not describe a "training set" as it would for a machine learning model. The studies described are clinical evaluations comparing the performance of the device to predicate devices. There is no mention of a separate training phase for the device itself.

9. How the Ground Truth for the Training Set Was Established

As there is no "training set" in the context of this physical device's evaluation, this question is not applicable.

Ask a specific question about this device